Medical News Today1d
Lenacapavir injection lowers HIV risk by 96%
Lenacapavir, an antiretroviral drug typically used to treat HIV infections, can also effectively prevent them, a phase 3 ...
Daily3h
Clinical trial reveals twice-yearly injection to be 96% effective in HIV prevention
For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including ...
Labroots13h
Twice Yearly Injection 96% Reduces HIV Infection Risk by 96%
A recent phase 3 trial found that twice-yearly injections of Lenacapavir reduce the risk of contracting HIV by 96%. | Drug ...
HIV prophylactic lenacapavir — very safe and very expensive
Health experts say lenacapavir could reduce the number of global HIV infections significantly. But it needs to be cheaper to ...
A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?
Drugmaker Gilead said it will allow cheap, generic versions to be sold in 120 poor countries with high HIV rates, mostly in ...
Six-Month HIV Prevention Shot Achieves 99% Efficacy in Major Study
Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...
India Today on MSN1d
New injection reduces risk of HIV infection by 96%: All about it
A new HIV prevention method, Lenacapavir, administered as a twice-yearly injection, has demonstrated superior results ...
Medscape19h
HIV ‘Game-Changer’ Drug: Is Eastern Europe Missing Out?
A new, long-acting injectable to prevent HIV infection could be a “game-changer” in ending the AIDS epidemic, if all who ...
Interesting Engineering on MSN1d
From chronic to curable: Twice-yearly shot shows near-total HIV eradication
Scientists have developed Lenacapavir, a twice-yearly injection that cuts HIV infection risk by 96% in groundbreaking trials.
'Huge relief' as new drug found to effectively prevent HIV infection
A vaccination with the drug lenacapavir offers an effective protection against a HIV infection, according to newly published ...